newsfilter
← Latest News
Business Wire·

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2022

Appili Therapeutics Inc. (TSX:APLI, OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases, today announced its financial and operational results for the third quarter of its fiscal year